COMPARE EFFECT OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS ON CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: CHEN, Yinhsuan (Department of Pharmacy, Wan Fang Hospital, Taipei Medical University, Taipei, China Taiwan)
- Co-author(s): Yinhsuan Chen
Diabetes mellitus (DM) is one of major risk factors for cardiovascular (CV) disease, inhibition of renin-angiotensin system in people with DM and hypertension may have unique advantages. However, the clinical effectiveness of angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) on CV risk in patients with type.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.